KRYS vs ZTS · P/E 46, rev $235.6M vs P/E 25, rev $2.47B
Krystal Biotech Inc (KRYS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the KRYS and ZTS stock pages for the full models.
Not investment advice.